A clinical pulmonologist sees a pattern emerge and becomes the first to identify vaping-induced lung disease (EVALI) in Utah.

Dr. Dixie Harris from Intermountain Healthcare joins me to talk about how her team helped identify the early cases, the role of telehealth in making that discovery, how we can evaluate and treat our patients with e-cigarette and vaping related lung disease, and much more.

Here’s some resources to help clinicians and patients understand the risks of EVALI.

Here’s a prior video I did on the risks of vaping.